These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18782999)

  • 21. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP; Kalantar-Zadeh K
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining the approach to IV iron use in hemodialysis patients: a post-DRIVE analysis.
    Sharma A; Vanderhalt K; Ryan KJ; Sclafani J
    Nephrol News Issues; 2010 Apr; 24(4):22-6, 29-35. PubMed ID: 20458992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron management in nondialysis-dependent CKD.
    Fishbane S
    Am J Kidney Dis; 2007 Jun; 49(6):736-43. PubMed ID: 17533016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing continuous quality improvement strategies for improving iron replacement in hemodialysis patients.
    Trenkle JA
    Nephrol Nurs J; 2001 Oct; 28(5):561-5. PubMed ID: 12143432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S; Naudeer S
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Principles of iron therapy in hemodialysis patients].
    Basić-Jukić N; Kes P; Jurić I
    Acta Med Croatica; 2006 Dec; 60(5):457-62. PubMed ID: 17217102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IV Iron: To Give or to Hold in the Presence of Infection in Adults Undergoing Hemodialysis.
    Hain D; Braun M
    Nephrol Nurs J; 2015; 42(3):279-83; quiz 284. PubMed ID: 26207288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correcting iron-restricted erythropoiesis and improving anemia in patients on hemodialysis: practical tips that can make a difference.
    Easom A
    Nephrol Nurs J; 2009; 36(5):529-37, 553. PubMed ID: 19856814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IV iron administration in a peritoneal dialysis clinic.
    Bush B
    Nephrol Nurs J; 2004; 31(4):447-8. PubMed ID: 15453239
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical evaluation of red blood cell ferritin and serum ferritin in maintenance hemodialysis patients (author's transl)].
    Futenma A; Okura T; Kawahara H
    Nihon Jinzo Gakkai Shi; 1982 Jan; 24(1):53-61. PubMed ID: 6808206
    [No Abstract]   [Full Text] [Related]  

  • 32. Important considerations in iron management and nutritional status in select hemodialysis populations.
    Olivares R
    Nephrol Nurs J; 2007; 34(4):425-32; quiz 433-4. PubMed ID: 17891911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More than a decade of experience and still no consensus: controversies in iron therapy.
    Besarab A
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371
    [No Abstract]   [Full Text] [Related]  

  • 35. A model for improving quality in nephrology settings.
    Manfredi SR; Canziani ME; Draibe SA; Dalboni MA; Andreolli MC; Watanabe R; Cendoroglo M
    Nephrol Nurs J; 2003 Jun; 30(3):295-9. PubMed ID: 12861897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations and challenges in defining optimal iron utilization in hemodialysis.
    Charytan DM; Pai AB; Chan CT; Coyne DW; Hung AM; Kovesdy CP; Fishbane S;
    J Am Soc Nephrol; 2015 Jun; 26(6):1238-47. PubMed ID: 25542967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Kim YH; Chung HH; Kang SB; Kim SC; Kim YT
    Acta Haematol; 2009; 121(1):37-41. PubMed ID: 19332985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Route of administration for erythropoiesis-stimulating agents: patient and nursing considerations.
    Holloway M
    Nephrol Nurs J; 2007; 34(5):527-31. PubMed ID: 18041455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia management: recognizing opportunities and improving outcomes through nursing interventions.
    Lewis M; Wick GS; Foret J
    Nephrol Nurs J; 2000 Oct; 27(5):507-12. PubMed ID: 16649326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of intravenous iron in clinical practice: implications for anemia management protocols.
    Aronoff GR
    J Am Soc Nephrol; 2004 Dec; 15 Suppl 2():S99-106. PubMed ID: 15585604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.